Literature DB >> 2497980

Role of interleukin-2 and interferon-gamma in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432.

H Yamaue1, H Tanimura, M Iwahashi, M Tani, T Tsunoda, K Tabuse, K Kuribayashi, K Saito.   

Abstract

The natural-killer(NK)-cell-mediated cytotoxicity to syngeneic tumor cells can be augmented by in vivo priming and subsequent in vitro challenge with the streptococcal preparation OK432. Supernatants of cocultures of spleen cells with OK432 contained interleukin-2 (IL-2) and interferon (IFN), mainly IFN-gamma. As the anti-(mouse IFN-gamma) monoclonal antibody but not anti-(mouse IFN-alpha) antibody inhibited the induction of activated NK cells with OK432, the IFN-gamma participated in this response. The enhancement of NK cell activity and production of IL-2 were partially inhibited by the pretreatment of spleen cells with mitomycin C or irradiation, and were completely abolished by pretreatment with actinomycin D. The IL-2 activity after treatment with various metabolic inhibitors ran parallel to the NK activity in a system augmented with OK432. The activity of incubated spleen cells with IL-2 receptors was increased by OK432 treatment, and the NK cell and IFN activities of supernatants were also abrogated by the treatment with anti-(mouse IL-2 receptor) monoclonal antibody, to block the interaction between IL-2 and these receptors of effector cells. The panning method clarified that the incubated spleen cells with IL-2 receptors are responsible for the production of IFN-gamma. These results suggest that IL-2 plays a major role in inducing the activated NK cells from murine spleen cells primed in vivo and subsequently challenged in vitro with OK432, by the production of IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2497980     DOI: 10.1007/bf00199281

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  42 in total

1.  Interferon-gamma induction in human peripheral blood mononuclear cells by OK-432, a killed preparation of Streptococcus pyogenes.

Authors:  T Noda; M Asano; O Yoshie; R Suzuki; T Ebina; N Ishida
Journal:  Microbiol Immunol       Date:  1986       Impact factor: 1.955

2.  Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen.

Authors:  C G Brooks; M Holscher; D Urdal
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

3.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

4.  Induction of interferon-gamma in mouse spleen cells by OK-432, a preparation of Streptococcus pyogenes.

Authors:  M Saito; T Ebina; M Koi; T Yamaguchi; Y Kawade; N Ishida
Journal:  Cell Immunol       Date:  1982-03-15       Impact factor: 4.868

5.  A rapid method for separating functionally intact human T lymphocytes with monoclonal antibodies.

Authors:  E L Reinherz; A C Penta; R E Hussey; S F Schlossman
Journal:  Clin Immunol Immunopathol       Date:  1981-11

6.  Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.

Authors:  K Oshimi; S Kano; F Takaku; K Okumura
Journal:  J Natl Cancer Inst       Date:  1980-12       Impact factor: 13.506

7.  Enhancement by poly-D-lysine of poly I: C-induced interferon production in mice.

Authors:  J M Rice; W Turner; M A Chirigos; N R Rice
Journal:  Appl Microbiol       Date:  1970-05

8.  Purified human interleukin-2 enhances induction of immune interferon.

Authors:  K T Pearlstein; M A Palladino; K Welte; J Vilcek
Journal:  Cell Immunol       Date:  1983-08       Impact factor: 4.868

9.  In vitro production of immune interferon (IFN gamma) by murine spleen cells when different sensitizing antigens are used in vivo and in vitro.

Authors:  M Saito; T Yamaguchi; T Ebina; M Koi; E Aonuma; H Usami; N Ishida
Journal:  Cell Immunol       Date:  1983-06       Impact factor: 4.868

10.  Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.

Authors:  A H Rook; J J Hooks; G V Quinnan; H C Lane; J F Manischewitz; A M Macher; H Masur; A S Fauci; J Y Djeu
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

View more
  7 in total

1.  In vitro generation of activated natural killer cells and cytotoxic macrophages with lentinan.

Authors:  M Tani; H Tanimura; H Yamaue; M Iwahashi; T Tsunoda; M Tamai; K Noguchi; K Arii
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Augmentation of antimetastatic effect on Lewis lung carcinoma (3LL) in C57BL/6 mice by priming with Lactobacillus casei.

Authors:  T Matsuzaki; Y Shimizu; T Yokokura
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

3.  Enhancement of natural killer cell activity in human immunodeficiency virus-infected subjects by in vitro treatment with biologic response modifier OK-432.

Authors:  X L Huang; Z Fan; T Murayama; C Rinaldo
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

4.  Successful immunochemotherapy for patients with malignant mesothelioma: report of two cases.

Authors:  M Tani; H Tanimura; H Yamaue; S Mizobata; M Yamamoto; M Iwahashi; K Ura; Y Nagai; T Tsunoda; H Wakasaki; K Nanjo; K Fujino; S Yukawa
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

5.  Significant antitumor effect of a synthetic lipid A analogue, DT-5461, on murine syngeneic tumor models.

Authors:  E Kumazawa; A Tohgo; T Soga; T Kusama; Y Osada
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

6.  Fibronectin promotes the proliferation of cytotoxic T lymphocytes generated from cancer patients.

Authors:  S Mizobata; H Tanimura; H Yamaue; M Tani; T Tsunoda; M Iwahashi; K Noguchi; N Nishimoto; T Hotta; K Arii
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

7.  Antitumor effects of interleukin-2 gene-modified fibroblasts in an orthotopic colon cancer model.

Authors:  H Terasawa; H Tanimura; M Nakamori; T Tsunoda; M Iwahashi; M Tani; H Yamaue
Journal:  Jpn J Cancer Res       Date:  1999-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.